The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS System in the treatment of Parkinson's disease. The utilization of Image Guided Programming (IGP), and other commercially available programming features, used as planning tools for the programming of patients with Boston Scientific's Vercise DBS System are also evaluated. Additionally, the utilization of the DBS Illumina 3D feature that may be used for the programming of patients with Boston Scientific's Vercise DBS Systems is also evaluated.
Parkinson's Disease
The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS System in the treatment of Parkinson's disease. The utilization of Image Guided Programming (IGP), and other commercially available programming features, used as planning tools for the programming of patients with Boston Scientific's Vercise DBS System are also evaluated. Additionally, the utilization of the DBS Illumina 3D feature that may be used for the programming of patients with Boston Scientific's Vercise DBS Systems is also evaluated.
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
-
Neurology and Pain Specialty, Aliso Viejo, California, United States, 92656
University of Colorado, Aurora, Colorado, United States, 80220
St. Mary's Hospital and Medical Center, Grand Junction, Colorado, United States, 81501
University of Florida Shands Hospital, Gainesville, Florida, United States, 32610
Mayo Clinic, Jacksonville, Jacksonville, Florida, United States, 32224
University of Miami Hospital, Miami, Florida, United States, 33136
Tallahassee Neurological Clinic, PA, Tallahassee, Florida, United States, 32308
University of South Florida, Tampa, Florida, United States, 33612
St. Luke Regional Medical Center, Boise, Idaho, United States, 83702
Rush University Medical Center, Chicago, Illinois, United States, 60612
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Boston Scientific Corporation,
Natalie Bloom Lyons, STUDY_DIRECTOR, Boston Scientific Neuromodulation Corporation
2038-12